Proteomic analysis of mucosal preparations from patients with ulcerative colitis

Molecular Medicine Reports

Volumn 1, Issue 1, 2008, Pages 51-54

  Fogt, Franz ^a   Jian, Bo ^a   Krieg, Rene C ^b   Wellmann, Axel ^c  

^a PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c Pathologisches Institut Celle   (Germany)

Author keywords

Desmin; Inflammation; Proteomics; Ulcerative colitis

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; CALDESMON; DESMIN; ISOLEUCINE; MEMBRANE PROTEIN; METHIONINE; SERINE; UNCLASSIFIED DRUG; VALINE; VESICULAR MEMBRANE PROTEIN P24;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; COLON MUCOSA; COLON RESECTION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEOMICS; SUBMUCOSA; TETRATRICOPEPTIDE REPEAT; TISSUE REPAIR; ULCERATIVE COLITIS; WESTERN BLOTTING;

EID: 69249148751     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Pierik M, Yang H, Barmada MM, Cavanaugh JA, Annese V, Brant SR, Cho JH, Duerr RH, Hugot JP, McGovern DP, Paavola- Sakki P, Radford-Smith GL, Pavli P, Silverberg MS, Schreiber S, Taylor KD and Vlietinck R: IBD International Genetics Consortium. The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction. Inflamm Bowel Dis 11: 1-7, 2005.
2. Perego RA, Bianchi C, Corizzato M, Eroini B, Torsello B, Valsecchi C, Di Fonzo A, Cordani N, Favini P, Ferrero S, Pitto M, Sarto C, Magni F, Rocco F and Mocarelli P: Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues. J Proteom Res 4: 1503-1510, 2005. (Pubitemid 41464774)
3. Seike M, Kondo T, Fujii K, Okano T, Yamada T, Matsuno Y, Gemma A, Kudoh S and Hirohashi S: Proteomic signatures for histological types of lung cancer. Proteomics 5: 2939-2948, 2005. (Pubitemid 41059770)
4. Kawakami T, Hoshida Y, Kanai F, Tanaka Y, Tateishi K, Ikenoue T, Obi S, Sato S, Teratani T, Shiina S, Kawabe T, Suzuki T, Hatano N, Taniguchi H and Omata M: Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment. Proteomics 5: 4287-4895, 2005. (Pubitemid 41626096)
5. Berman DM, Shih IeM, Burke LA, Veenstra TD, Zhao Y, Conrads TP, Kwon SW, Hoang V, Yu LR, Zhou M, Kurman RJ, Petricoin EF and Liotta LA: Profiling the activity of G proteins in patient-derived tissues by rapid affinity-capture of signal transduction proteins (GRASP). Proteomics 4: 812-818, 2004. (Pubitemid 38339158)
6. Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Lattimore S, Akada M, Sunamura M, Prime W, Campbell F, Brentnall TA, Costello E, Neoptolemos J and Lemoine NR: Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 129: 1454-1463, 2005. (Pubitemid 41597388)
7. Barcelo-Batllori S, Andre M, Servis C, Levy N, Takikawa O, Michetti P, Reymond M and Felley-Bosco E: Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics 2: 551-560, 2002. (Pubitemid 34507345)
8. Okazaki N, Takahashi N, Kojima S, Masuho Y and Koga H: Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis 23: 1139-1148, 2002. (Pubitemid 34814771)
9. Carrell RW: alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage. J Clin Invest 78: 1427-1431, 1986.
10. Faust D, Raschke K, Hormann S, Milovic V and Stein J: Regulation of alpha1-proteinase inhibitor release by proinflammatory cytokines in human intestinal epithelial cells. Clin Exp Immunol 128: 279-284, 2002. (Pubitemid 34534041)
11. Wright JP, Young GO and Tigler-Wybrandi N: Predictors of acute relapse of Crohn's disease. A laboratory and clinical study. Dig Dis Sci 32: 164-170, 1987.
12. Stahl M, Ludwig D, Fellermann and Stange EF: Intestinal expression of human heat shock protein 90 in patients with Crohn's disease and ulcerative colitis. Dig Dis Sci 43: 1079-1087, 1998. (Pubitemid 28211470)
13. Nakayama H, Miyazaki E and Enzan H: Differential expression of high molecular weight caldesmon in colorectal pericryptal fibroblasts and tumour stroma. J Clin Pathol 52: 785-786, 1999. (Pubitemid 29481345)
14. Helfman DM, Levy ER, Berthier C, et al: Caldesmon inhibits nonmuscle cell contractility and interferes with the formation of focal adhesions. Mol Biol Cell 10: 3097-3112, 1999. (Pubitemid 29489548)
15. Arias MP and Pacaud M: Macrophage caldesmon is an actin bundling protein. Biochemistry 40: 12974-12982, 2001.
16. Scaife S, Brown R, Kellie S, Filer A, Martin S, Thomas AM, Bradfield PF, Amft N, Salmon M and Buckley CD: Detection of differentially expressed genes in synovial fibroblasts by restriction fragment differential display. Rheumatology 43: 1346-1352, 2004. (Pubitemid 39480920)
17. Bar H, Fischer D, Goudeau B, Kley RA, Clemen CS, Vicart P, Herrmann H, Vorgerd M and Schroder R: Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. Hum Mol Genet 14: 1251-1260, 2005. (Pubitemid 40744485)
18. Pruszczyk P, Kostera-Pruszczyk A, Shatunov A, Goudeau B, Draminska A, Takeda K, Sambuughin N, Vicart P, Strelkov SV, Goldfarb LG and Kaminska A: Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation. Int J Cardiol 117: 244-253, 2007. (Pubitemid 46463982)
19. Park KY, Dalakas MC, Semino-Mora C, Lee HS, Litvak S, Takeda K, Ferrans VJ and Goldfarb LG: Sporadic cardiac and skeletal myopathy caused by a de novo desmin mutation. Clin Genet 57: 423-429, 2000. (Pubitemid 30843794)